New therapeutic strategy against peritoneal sclerosis using gene-modified macrophages
使用基因修饰巨噬细胞对抗腹膜硬化的新治疗策略
基本信息
- 批准号:18590893
- 负责人:
- 金额:$ 2.45万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2006
- 资助国家:日本
- 起止时间:2006 至 2007
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Peritoneal sclerosis is one of the serious complications among the patients with peritoneal dialysis and it prevents long-term peritoneal dialysis therapy. However, the pathogenesis of peritoneal sclerosis remains unknown. In pathological examination, accumulation of macrophages is observed in some patients with peritoneal sclerosis and experimental peritoneal sclerosis model. In this study, we examined an important role of macrophages during the development of peritoneal sclerosis and we tried whether the development of peritoneal sclerosis can be prevented using gene-modified macrophages.It is well known that macrophages infiltrate into inflamed tissue via adhesion molecule and that ICAM-1 is known as one of important adhesion molecules in macrophage infiltration. Firstly, we studied a role of macrophages during the course of peritoneal sclerosis, using ICAM-1(intracellular adhesion molecule)knockout mice using experimental peritoneal sclerosis model with chlorhexidine gluconate. Com … More paring with wild type, ICAM-1 knockout model, macrophage was hardly observed in peritoneal tissue and submesothelial tissue thickening was significantly suppressed From the results, accumulated macrophages in thickened submesothelial tissue plays an important role in development of peritoneal sclerosis.Secondly, gene-modified macrophages were made using cationized gelatin(kindly gifted from Professor Yasuhiko Tabata in Kyoto University) with hepatic growth factor(HGF) gene, which is known to work as antifibrotic factor. We fried to utilize macrophages as a vehicle to express and deliver HGF gene at the peritoneum because macrophages have phagocytotic activity and are capable of migrating to inflamed sites. Intravenous transfer of macrophages carrying HGF expression vector significantly suppressed the submesothelial thickening and reduced collagen III expression in chlorhexidine treated mice.In conclusion, macrophages have a central role of pathogenesis of peritoneal sclerosis and gene-modified macrophages with cationized gelatin including HGF gene may open a new therapeutic strategy against peritoneal sclerosis. Further studies are necessary for applying this method in the patients with peritoneal dialysis as tool of preventing and inhibiting peritoneal sclerosis. Less
腹膜硬化是腹膜透析患者的严重并发症之一,它可以防止长期的腹膜透析治疗。但是,腹膜硬化的发病机理仍然未知。在病理检查中,在一些腹膜硬化症和实验性腹膜硬化模型的患者中观察到巨噬细胞的积累。在这项研究中,我们检查了巨噬细胞在腹膜硬化的发展过程中的重要作用,并尝试使用基因改性的巨噬细胞可以预防腹膜硬化的发展。众所周知,巨噬细胞通过粘合剂分子浸润到炎症的组织中,并知道ICAM-1是重要的粘合菌丝中的重要的粘合物。首先,我们使用ICAM-1(细胞内粘合分子)基因敲除小鼠研究了巨噬细胞在腹膜硬化过程中的作用。 com…在腹膜组织中几乎没有观察到巨噬细胞的野生型,ICAM-1基因敲除模型,并在腹膜组织中观察到巨噬细胞,并从结果中显着抑制了巨噬细胞,从结果中显着抑制,在增厚的质体组织中累积的巨噬细胞在腹膜硬化的发育中起着重要的作用。其次,使用甲状腺含量(HGF)基因的阳离子明胶(从京都大学的Yasuhiko Tabata教授那里赠予基因化的巨噬细胞(从Yasuhiko Tabata教授那里),该基因被称为抗纤维化因子。由于巨噬细胞具有吞噬活性,并且能够迁移到发炎的部位,因此我们油炸以利用巨噬细胞作为媒介物表达和传递HGF基因。 Intravenous transfer of macrophages carrying HGF expression vector significantly suppressed the submesothelial thickening and reduced collagen III expression in chlorhexidine treated mice.In conclusion, macrophages have a central role of pathogenesis of peritoneal sclerosis and gene-modified macrophages with cationized gelatin including HGF gene may open a new therapeutic strategy against peritoneal sclerosis.进一步的研究对于在腹膜透析患者中应用这种方法是预防和抑制腹膜硬化症的工具。较少的
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Japanese extraneal collaborated study group:Effects of icodextrin on glycemic and lipid profiles in diabetic patients undergoing peritoneal dialysis.
日本体外合作研究小组:艾考糊精对接受腹膜透析的糖尿病患者血糖和血脂的影响。
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Babazono T;Nakamoto H;Kasai K;Kuriyama S;Suginoto T;Nakayama M;Hamada T;Furuya R;Hasegawa H;Kasahara M;Moriishi M;Miyazaki M;Sato M;Yorioka N;Kawaguchi Y
- 通讯作者:Kawaguchi Y
Mizoribine induces remission of relapsed ANCA-associated renal vasculitis
米佐立宾诱导复发性 ANCA 相关肾血管炎的缓解
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Nishioka;Y.;Horita;Y.;Tadokoro;M.;Taura;K.;Suyama;N.;Miyazaki;M.;Harada;T.;Kohno;S
- 通讯作者:S
Changing mizoribine administration from three divided doses to one single dose induced remission of relapsed membranous nephropathy
- DOI:10.1093/ndt/gfl108
- 发表时间:2006-08-01
- 期刊:
- 影响因子:6.1
- 作者:Nishioka, Yoshiaki;Horita, Yoshio;Kohno, Shigeru
- 通讯作者:Kohno, Shigeru
Involvement of leptin in development of fibrosis in mice experimental model of eritoneal dialysis
瘦素参与小鼠腹膜透析实验模型纤维化的发生
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Nakazawa;M.;Abe;K.;Miyazaki;M.;et. al.
- 通讯作者:et. al.
Mizoribine induces remission of relapsed ANCA-associated renal vaculitis.
Mizoribine 可诱导复发性 ANCA 相关肾血管炎的缓解。
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Nishioka Y;Horita Y;Tadokoro M;Taura K;Suyama N;Miyazaki M;Harada T;Kohno S
- 通讯作者:Kohno S
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MIYAZAKI Masanobu其他文献
MIYAZAKI Masanobu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MIYAZAKI Masanobu', 18)}}的其他基金
Peritoneal membrane regeneration in peritoneal sclerosis
腹膜硬化中的腹膜再生
- 批准号:
16590789 - 财政年份:2004
- 资助金额:
$ 2.45万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanism of spontaneous remission from renal injury
肾损伤自发缓解的分子机制
- 批准号:
13671118 - 财政年份:2001
- 资助金额:
$ 2.45万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
丙酮酸羧化酶乳酸化修饰介导TCA回补途径调控肺泡巨噬细胞极化在脓毒症ARDS中的机制研究
- 批准号:82300100
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
circPVT1-miR-125b/miR-200a介导循环和驻留巨噬细胞在移植心脏冷缺血再灌注损伤中的作用机制
- 批准号:82360066
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
红系造血岛巨噬细胞TLR8信号激活在再生障碍性贫血中机制研究
- 批准号:82370144
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
TLR3介导巨噬细胞M2极化调控BMSCs成骨分化延缓骨质疏松症的作用机制及右归丸的干预研究
- 批准号:82374486
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
代谢工程化MSC胞外囊泡靶向调控巨噬细胞线粒体动力学改善急性肾损伤的作用及机制研究
- 批准号:32371426
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
A macrophage-centric holistic view of postnatal development
以巨噬细胞为中心的产后发育整体观
- 批准号:
DP240102888 - 财政年份:2024
- 资助金额:
$ 2.45万 - 项目类别:
Discovery Projects
Alterations in macrophage metabolism in heart failure with preserved ejection
射血保留性心力衰竭患者巨噬细胞代谢的改变
- 批准号:
502586 - 财政年份:2024
- 资助金额:
$ 2.45万 - 项目类别:
The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
- 批准号:
24K19237 - 财政年份:2024
- 资助金额:
$ 2.45万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Macrophage-polarizing ALMA hydrogels for thyroid regeneration following radiation injury
巨噬细胞极化 ALMA 水凝胶用于放射损伤后甲状腺再生
- 批准号:
MR/Y033817/1 - 财政年份:2024
- 资助金额:
$ 2.45万 - 项目类别:
Research Grant
ERI: Biological Effects of Low-Frequency, Low-Intensity Ultrasound on Endothelial Cell and Macrophage Co-Culture
ERI:低频、低强度超声对内皮细胞和巨噬细胞共培养的生物学效应
- 批准号:
2347558 - 财政年份:2024
- 资助金额:
$ 2.45万 - 项目类别:
Standard Grant